AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Amoxicillin+ Potassium Clavulanate in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Augmentin BD SF suspension Suspension for Oral Use | 179/046 | GlaxoSmithKline South Africa (Pty) Ltd | active | 18 Mar 2030 |
Amoxicillin+ Potassium Clavulanate — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Amoxicillin+ Potassium Clavulanate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Amoxicillin+ Potassium Clavulanate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.